Pfizer gains full FDA approval

14:18, 24 August 2021
Pfizer gains full FDA approval Photo: U.S. Secretary of Defense/

The Food and Drug Administration of the US Departments of Health and Human Services has granted the COVID vaccine developed by the  Pharmaceutical company Pfizer full approval.

A full approval means that now the vaccine can be considered safe and used for people as young as 16.

"The FDA's approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA's rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product," Janet Woodcock, FDA Commissioner said in a statement.

It is expected that more people will consider getting vaccinated now that Pfizer got the FDA approval.

“While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today's milestone puts us one step closer to altering the course of this pandemic in the U.S.," Woodcock said.

Pfizer’s shares rallied 2,48% following the news as Pfizer’s vaccine is the first one to get a full FDA approval. 

Earlier, anti-vaxxers broke into the headquarters of British broadcaster Independent Television News (ITN) in London, demanding the broadcaster to tell the truth about vaccination passports and children jabs.